National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. [electronic resource]
Producer: 20040427Description: 163-72 p. digitalISSN:- 0167-5273
- Aged
- Angina, Unstable -- drug therapy
- Anticoagulants -- adverse effects
- Cardiac Catheterization
- Coronary Angiography
- Coronary Disease -- drug therapy
- Electrocardiography -- economics
- Female
- Hemorrhage -- chemically induced
- Heparin -- adverse effects
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- drug therapy
- Patient Admission
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- adverse effects
- Predictive Value of Tests
- Prospective Studies
- Risk Factors
- Sensitivity and Specificity
- Syndrome
- Tirofiban
- Treatment Outcome
- Tyrosine -- adverse effects
- United Kingdom -- epidemiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.